{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:45:30Z","timestamp":1760298330088},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,11,27]],"date-time":"2010-11-27T00:00:00Z","timestamp":1290816000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s13277-010-0126-5","type":"journal-article","created":{"date-parts":[[2010,11,26]],"date-time":"2010-11-26T07:52:47Z","timestamp":1290757967000},"page":"335-346","source":"Crossref","is-referenced-by-count":22,"title":["The G1 phase arrest and apoptosis by intrinsic pathway induced by valproic acid inhibit proliferation of BGC-823 gastric carcinoma cells"],"prefix":"10.1007","volume":"32","author":[{"given":"Xia","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changwen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanshan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guosheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,27]]},"reference":[{"key":"126_CR1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1172\/JCI0216547","volume":"110","author":"HT Spotswood","year":"2002","unstructured":"Spotswood HT, Turner BM. An increasingly complex code. J Clin Invest. 2002;110:577\u201382.","journal-title":"J Clin Invest"},{"key":"126_CR2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0092-8674(02)01080-2","volume":"111","author":"BM Turner","year":"2002","unstructured":"Turner BM. Cellular memory and the histone code. Cell. 2002;111:285\u201391.","journal-title":"Cell"},{"key":"126_CR3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2174\/1566524013363537","volume":"1","author":"SG Gray","year":"2001","unstructured":"Gray SG, Teh BT. Histone acetylation\/deacetylation and cancer: an \u201copen\u201d and \u201cshut\u201d case? Curr Mol Med. 2001;1:401\u201329.","journal-title":"Curr Mol Med"},{"key":"126_CR4","first-page":"194","volume":"1","author":"PA Marks","year":"2001","unstructured":"Marks PA, Rifkind RA, Richon VM, et al. Histone deacetylases and cancer: causes and therapies. Nature. 2001;1:194\u2013202.","journal-title":"Nature"},{"key":"126_CR5","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1038\/sj.bjc.6600319","volume":"86","author":"A Satoh","year":"2002","unstructured":"Satoh A, Toyota M, Itoh F, et al. DNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancers. Br J Cancer. 2002;86:1817\u201323.","journal-title":"Br J Cancer"},{"issue":"2","key":"126_CR6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/1568009043481560","volume":"4","author":"DM Vigushin","year":"2004","unstructured":"Vigushin DM, Coombes RC. Targeted histone deacetylase inhibition for cancer therapy. Curr Cancer Drug Targets. 2004;4(2):205\u201318.","journal-title":"Curr Cancer Drug Targets"},{"key":"126_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00001813-200201000-00001","volume":"13","author":"DM Vigushin","year":"2002","unstructured":"Vigushin DM, Coombes RC. Histone deacetylase inhibitors in cancer treatment. Anticancer Drugs. 2002;13:1\u201313.","journal-title":"Anticancer Drugs"},{"key":"126_CR8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/jcb.20532","volume":"96","author":"M Dokmanovic","year":"2005","unstructured":"Dokmanovic M, Marks PA. Prospects: histone deacetylase inhibitors. J Cell Biochem. 2005;96:293\u2013304.","journal-title":"J Cell Biochem"},{"key":"126_CR9","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1126\/science.1066726","volume":"294","author":"A Bird","year":"2001","unstructured":"Bird A. Methylation talk between histone and DNA. Science. 2001;294:2113\u20135.","journal-title":"Science"},{"key":"126_CR10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1046-2023(02)00028-2","volume":"26","author":"GW Aherne","year":"2002","unstructured":"Aherne GW, Rowlands MG, Stimson L, et al. Assays for the identification and evaluation of histone acetyltransferase inhibitors. Methods. 2002;26:245\u201353.","journal-title":"Methods"},{"key":"126_CR11","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1038\/sj.onc.1204323","volume":"20","author":"FD Urnov","year":"2001","unstructured":"Urnov FD, Wolffe AP. Chromatin remodeling and transcriptional activation: the cast (in order of appearance). Oncogene. 2001;20:2991\u20133006.","journal-title":"Oncogene"},{"key":"126_CR12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ctrv.2004.04.006","volume":"30","author":"R Somech","year":"2004","unstructured":"Somech R, Izraelia S, Simon AJ. Histone deacetylase inhibitors: a new tool to treat cancer. Cancer Treat Rev. 2004;30:461\u201372.","journal-title":"Cancer Treat Rev"},{"key":"126_CR13","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.leukres.2004.11.022","volume":"29","author":"H Yang","year":"2005","unstructured":"Yang H, Hoshino K, Sanchez-Gonzalez B, et al. Antileukemia activity of the combination of 5-aza-2\u2032-deoxycytidine with valproic acid. Leuk Res. 2005;29:739\u201348.","journal-title":"Leuk Res"},{"key":"126_CR14","first-page":"97","volume":"20","author":"J Cinatl Jr","year":"2002","unstructured":"Cinatl Jr J, Kotchetkov R, Blaheta R, et al. Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE (2)-C cells by valproic acid: enhancement by combination with interferon-alpha. Int J Oncol. 2002;20:97\u2013106.","journal-title":"Int J Oncol"},{"key":"126_CR15","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1189\/jlb.1103581","volume":"76","author":"A Moldenhauer","year":"2004","unstructured":"Moldenhauer A, Frank RC, Pinilla-Ibarz J, et al. Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins. J Leukoc Biol. 2004;76:623\u201333.","journal-title":"J Leukoc Biol"},{"key":"126_CR16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/sj.bjc.6601510","volume":"90","author":"R Kuefer","year":"2004","unstructured":"Kuefer R, Hofer MD, Altug V, et al. Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer. Br J Cancer. 2004;90:535\u201341.","journal-title":"Br J Cancer"},{"key":"126_CR17","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1074\/jbc.M106699200","volume":"277","author":"SH Known","year":"2002","unstructured":"Known SH, Ahn SH, Kim YK, et al. Apicidin, a histone deacetylase inhibitor, induces apoptosis and FAS\/FAS ligand expression in human acute promielocytic leukemia cells. J Biol Chem. 2002;277:2073\u201380.","journal-title":"J Biol Chem"},{"key":"126_CR18","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1182\/blood-2002-12-3794","volume":"102","author":"JL Aron","year":"2003","unstructured":"Aron JL, Parthun MR, Marucci G, et al. Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cell concurrent with activation of Caspase 8-mediated apoptosis and downregulation of c-FLIP protein. Blood. 2003;102:652\u20138.","journal-title":"Blood"},{"key":"126_CR19","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1093\/emboj\/cdg414","volume":"22","author":"DW Chang","year":"2003","unstructured":"Chang DW, Xing Z, Capacio VL, et al. Inter-dimer processing mechanism of procaspase-8 activation. EMBO J. 2003;22:4132\u201342.","journal-title":"EMBO J"},{"key":"126_CR20","first-page":"4460","volume":"63","author":"MJ Peart","year":"2003","unstructured":"Peart MJ, Tainton KM, Rurefli AA, et al. Novel mechanisms of apoptosis induced by histone deacetylase inhibitors. Cancer Res. 2003;63:4460\u201371.","journal-title":"Cancer Res"},{"key":"126_CR21","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1158\/1078-0432.CCR-03-0561","volume":"10","author":"XY Pei","year":"2004","unstructured":"Pei XY, Dai Y, Grant S, et al. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors. Clin Cancer Res. 2004;10:3839\u201352.","journal-title":"Clin Cancer Res"},{"key":"126_CR22","doi-asserted-by":"crossref","unstructured":"Gao LW, Zhang J, Yang WH, Wang B, Wang JW. Glaucocalyxin A induces apoptosis in human leukemia HL-60 cells through mitochondria-mediated death pathway. Toxicol In Vitro. 2010; [Epub ahead of print]","DOI":"10.1016\/j.tiv.2010.09.006"},{"key":"126_CR23","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.272.5260.408","volume":"272","author":"J Taunton","year":"1996","unstructured":"Taunton J, Hassig CA, Schreiber SL. A mammalian histone deacetylase related tothe yeast transc riptional regulator Rpd3p. Science. 1996;272:408\u201311.","journal-title":"Science"},{"key":"126_CR24","first-page":"2045","volume":"21","author":"M Abdul","year":"2001","unstructured":"Abdul M, Hoosein N. Inhibition by anticonvulsants of prostate-specific antigen and interleukin-6 secretion by human prostate cancer cells. Anticancer Res. 2001;21:2045\u20138.","journal-title":"Anticancer Res"},{"key":"126_CR25","first-page":"1139","volume":"13","author":"P Rocchi","year":"2005","unstructured":"Rocchi P, Tonelli R, Camerin C, et al. p21Waf1\/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells. Oncol Rep. 2005;13:1139\u201344.","journal-title":"Oncol Rep"},{"key":"126_CR26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1006\/exer.1998.0810","volume":"70","author":"R Vento","year":"2000","unstructured":"Vento R, D\u2019Alessandro N, Giuliano M, et al. Induction of apoptosis by arachidonic acid in human retinoblastoma Y79 cells: involvement of oxidative stress. Exp Eye Res. 2000;70:503\u201317.","journal-title":"Exp Eye Res"},{"key":"126_CR27","first-page":"8955","volume":"63","author":"A Gozzini","year":"2003","unstructured":"Gozzini A, Rovida E, Sbarba PD, et al. Butyrates, as a single drug, induce histone acetylation and granulocytic maturation: possible selectivity on corebinding factor\u2014acute myeloid leukemia blasts. Cancer Res. 2003;63:8955\u201361.","journal-title":"Cancer Res"},{"key":"126_CR28","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1210\/jc.2003-031407","volume":"82","author":"N Fortunati","year":"2004","unstructured":"Fortunati N, Catalano MG, Arena K, et al. Valproic acid induces the expression of the Na+\/I- symporter and iodine uptake in poorly differentiated thyroid cancer cells. J Clin Endocrinol Metab. 2004;82:1006\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"126_CR29","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1158\/1078-0432.CCR-06-0367","volume":"12","author":"QT Luong","year":"2006","unstructured":"Luong QT, O\u2019Kelly J, Braunstein GD, et al. Antitumor activity of suberoylanilide hydroxamic acid against thyroid cancer cell lines in vitro and in vivo. Clin Cancer Res. 2006;12:5570\u20137.","journal-title":"Clin Cancer Res"},{"key":"126_CR30","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/nature04985","volume":"442","author":"MF Tsou","year":"2006","unstructured":"Tsou MF, Stearns T. Mechanism limiting centrosome duplication to once per cell cycle. Nature. 2006;442:947\u201351.","journal-title":"Nature"},{"key":"126_CR31","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1210\/jc.2004-1355","volume":"90","author":"MG Catalano","year":"2005","unstructured":"Catalano MG, Fortunati N, Pugliese M, et al. Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells. J Clin Endocrinol Metab. 2005;90:1383\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"126_CR32","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.3748\/wjg.v9.i11.2450","volume":"9","author":"Q Zhou","year":"2003","unstructured":"Zhou Q, He Q, Liang LJ. Expression of p27, Cyclin E and Cyclin A in hepatocellular carcinoma and its clinical significance. World J Gastroenterol. 2003;9:2450\u20134.","journal-title":"World J Gastroenterol"},{"key":"126_CR33","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1053\/j.seminoncol.2005.07.009","volume":"32","author":"M Macaluso","year":"2005","unstructured":"Macaluso M, Montanari M, Cinti C. Modulation of cell cycle components by epigenetic and genetic events. Semin Oncol. 2005;32:452\u20137.","journal-title":"Semin Oncol"},{"key":"126_CR34","first-page":"863","volume":"26","author":"SM Pulukuri","year":"2005","unstructured":"Pulukuri SM, Rao JS. Activation of p53\/p21Waf1\/Cip1 pathway by 5-aza-2\u2032-deoxycytidine inhibits cell proliferation, induces pro-apoptotic genes and mitogen-activated protein kinases in human prostate cancer cells. Int J Oncol. 2005;26:863\u201371.","journal-title":"Int J Oncol"},{"key":"126_CR35","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00277-005-0006-z","volume":"84","author":"A Gozzini","year":"2005","unstructured":"Gozzini A, Santini V. Butyrates and decitabine cooperate to induce histone acetylation and granulocytic maturation of t(8;21) acute myeloid leukemia blasts. Ann Hematol. 2005;84:54\u201360.","journal-title":"Ann Hematol"},{"key":"126_CR36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ijc.11697","volume":"109","author":"H Kobayashi","year":"2004","unstructured":"Kobayashi H, Tan EM, Fleming SE. Acetylation of histones associated with the p21WAF1\/CIP1 gene by butyrate is not sufficient for p21WAF1\/CIP1 gene transcription in human colorectal adenocarcinoma cells. Int J Cancer. 2004;109:207\u201313.","journal-title":"Int J Cancer"},{"key":"126_CR37","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1349-7006.2006.00195.x","volume":"97","author":"HY Park","year":"2006","unstructured":"Park HY, Kim MK, Moon SI, et al. Cell cycle arrest and apoptotic induction in LNCaP cells by MCS-C2, novel cyclin-dependent kinase inhibitor, through p53\/p21WAF1\/CIP1 pathway. Cancer Sci. 2006;97:430\u20136.","journal-title":"Cancer Sci"},{"key":"126_CR38","first-page":"2439","volume":"11","author":"HQ Nguyen","year":"1995","unstructured":"Nguyen HQ, Selvakumaran M, Liebermann DA, Hoffman B. Blocking c-Myc and Max expression inhibits proliferation and induces differentiation of normal and leukemic myeloid cells. Oncogene. 1995;11:2439\u201344.","journal-title":"Oncogene"},{"key":"126_CR39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0065-230X(02)84004-0","volume":"84","author":"SK Oster","year":"2002","unstructured":"Oster SK, Ho CS, Soucie EL, Penn LZ. The Myc oncogene: marvelously complex. Adv Cancer Res. 2002;84:81\u2013154.","journal-title":"Adv Cancer Res"},{"key":"126_CR40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0960-9822(06)00183-7","volume":"7","author":"A Sommer","year":"1997","unstructured":"Sommer A, Hilfenhaus S, Menkel A, et al. Cell growth inhibition by the Mad\/Max complex through recruitment of histone deacetylase activity. Curr Biol. 1997;7:357\u201365.","journal-title":"Curr Biol"},{"key":"126_CR41","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1073\/pnas.050586197","volume":"97","author":"H Hermeking","year":"2000","unstructured":"Hermeking H, Rago C, Schuhmacher M, et al. Identification of CDK4 as a target of c-MYC. Proc Natl Acad Sci USA. 2000;97:2229\u201334.","journal-title":"Proc Natl Acad Sci USA"},{"key":"126_CR42","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/387422a0","volume":"387","author":"L Gustavo","year":"1997","unstructured":"Gustavo L, James D, Rosalie S, Laszlo J, Joseph R. Myc and Ras collaborate in inducing accumulation of active cyclin E\/Cdk2 and E2F. Nature. 1997;387:422\u20136.","journal-title":"Nature"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-010-0126-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-010-0126-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-010-0126-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T15:23:16Z","timestamp":1559834596000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-010-0126-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,27]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["126"],"URL":"https:\/\/doi.org\/10.1007\/s13277-010-0126-5","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,27]]}}}